Goss PE - Search Results

1

Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy.

Chavarri-Guerra Y, Higgins MJ, Szymonifka J, Cigler T, Liedke P, Partridge A, Ligibel J, Come SE, Finkelstein D, Ryan PD, Goss PE. Chavarri-Guerra Y, et al. Among authors: goss pe. Br J Cancer. 2014 Nov 25;111(11):2046-50. doi: 10.1038/bjc.2014.502. Epub 2014 Sep 18. Br J Cancer. 2014. PMID: 25233398 Free PMC article. Clinical Trial.

2

Adjuvant hormonal therapy in peri- and postmenopausal breast cancer.

Ryan PD, Goss PE. Ryan PD, et al. Among authors: goss pe. Oncologist. 2006 Jul-Aug;11(7):718-31. doi: 10.1634/theoncologist.11-7-718. Oncologist. 2006. PMID: 16880231 Free article. Review.

3

Breast cancer adjuvant endocrine therapy.

Cigler T, Goss PE. Cigler T, et al. Among authors: goss pe. Cancer J. 2007 May-Jun;13(3):148-55. doi: 10.1097/PPO.0b013e318074d363. Cancer J. 2007. PMID: 17620763 Review.

4

Extended adjuvant endocrine therapy in hormone dependent breast cancer: the paradigm of the NCIC-CTG MA.17/BIG 1-97 trial.

Higgins MJ, Liedke PE, Goss PE. Higgins MJ, et al. Among authors: goss pe. Crit Rev Oncol Hematol. 2013 Apr;86(1):23-32. doi: 10.1016/j.critrevonc.2012.09.013. Epub 2012 Oct 30. Crit Rev Oncol Hematol. 2013. PMID: 23116626 Review.

5

Intermittent letrozole therapy for metastatic breast cancer: case reports and literature review.

Fan L, Liedke PE, Isakoff SJ, St Louis J, Ryan PD, Goss PE. Fan L, et al. Among authors: goss pe. Clin Breast Cancer. 2014 Apr;14(2):e41-5. doi: 10.1016/j.clbc.2013.10.009. Epub 2013 Oct 25. Clin Breast Cancer. 2014. PMID: 24342729 Review. No abstract available.

6

The evolving role of aromatase inhibitors in the treatment of early-stage breast cancer.

Ryan PD, Goss PE. Ryan PD, et al. Among authors: goss pe. Nat Clin Pract Oncol. 2005 Dec;2(12):596-7. doi: 10.1038/ncponc0360. Nat Clin Pract Oncol. 2005. PMID: 16341095 No abstract available.

7

Aromatase inhibitor withdrawal response in metastatic breast cancer.

Cigler T, Goss PE. Cigler T, et al. Among authors: goss pe. J Clin Oncol. 2006 Apr 20;24(12):1955-6. doi: 10.1200/JCO.2005.03.4108. J Clin Oncol. 2006. PMID: 16622274 No abstract available.

8

Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference.

Come SE, Buzdar AU, Ingle JN, Johnston SRD, Brodie AM, Coombes RC, Miller WR, Pritchard KI, Winer EP, Zujewski JA, Goss PE. Come SE, et al. Among authors: goss pe. Cancer. 2008 Feb 1;112(3 Suppl):673-678. doi: 10.1002/cncr.23194. Cancer. 2008. PMID: 18072254 Free article.

9

Denosumab and the current status of bone-modifying drugs in breast cancer.

Lee BL, Higgins MJ, Goss PE. Lee BL, et al. Among authors: goss pe. Acta Oncol. 2012 Feb;51(2):157-67. doi: 10.3109/0284186X.2011.633555. Epub 2011 Dec 12. Acta Oncol. 2012. PMID: 22150116 Review.

10

Breast cancer in Brazil: present status and future goals.

Lee BL, Liedke PE, Barrios CH, Simon SD, Finkelstein DM, Goss PE. Lee BL, et al. Among authors: goss pe. Lancet Oncol. 2012 Mar;13(3):e95-e102. doi: 10.1016/S1470-2045(11)70323-0. Lancet Oncol. 2012. PMID: 22381937 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters